These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9779061)

  • 21. Thrombolytic therapy for venous thromboembolism. Complications and contraindications.
    Levine MN
    Clin Chest Med; 1995 Jun; 16(2):321-8. PubMed ID: 7656543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound-accelerated thrombolysis in arterial and venous peripheral occlusions: fibrinogen level effects.
    Raabe RD
    J Vasc Interv Radiol; 2010 Aug; 21(8):1165-72. PubMed ID: 20656221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Local thrombolytic treatment of peripheral arterial thrombosis and embolism].
    Staxrud LE; Schilvold A; Ly B; Rosén L; Line PD; Kroese A; Jørgensen JJ
    Tidsskr Nor Laegeforen; 1996 Oct; 116(25):2996-9. PubMed ID: 8975422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The status of thrombolysis in treatment of peripheral arterial occlusive diseases].
    Tjon-a-Meeuw L; Schneider E; Bollinger A
    Internist (Berl); 1992 Apr; 33(4):232-40. PubMed ID: 1612847
    [No Abstract]   [Full Text] [Related]  

  • 25. [Thrombolytic therapy of arterial occlusions].
    Rauber K
    Z Gesamte Inn Med; 1993; 48(6-7):344-50. PubMed ID: 8333231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis.
    Agle SC; McNally MM; Powell CS; Bogey WM; Parker FM; Stoner MC
    Ann Vasc Surg; 2010 Jul; 24(5):609-14. PubMed ID: 20413257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombolytic therapy of peripheral arterial occlusion with recombinant staphylokinase.
    Vanderschueren S; Stockx L; Wilms G; Lacroix H; Verhaeghe R; Vermylen J; Collen D
    Circulation; 1995 Oct; 92(8):2050-7. PubMed ID: 7554181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fibrinolytic agents--who benefits when?].
    Weichert W; Seifried E
    Ther Umsch; 1995 Oct; 52(10):652-60. PubMed ID: 7482376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thrombolytic agents].
    Lablanche JM
    Rev Prat; 1989 Feb; 39(3):259-62. PubMed ID: 2922567
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of tenecteplase in peripheral embolic disease.
    Bannerjee AK; Dastidar DG
    Indian Heart J; 2010; 62(4):313-5. PubMed ID: 21280470
    [No Abstract]   [Full Text] [Related]  

  • 31. Low-dose thrombolysis for thromboembolic lower extremity arterial occlusions is effective without major hemorrhagic complications.
    Ebben HP; Nederhoed JH; Lely RJ; Meijerink MR; van der Meijs BB; Wisselink W; Yeung KK; Hoksbergen AW
    Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):551-8. PubMed ID: 25108710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgery versus thrombolytic therapy in the management of peripheral arterial occlusions.
    Ouriel K
    J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):48S-54S. PubMed ID: 8770842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fibrinolytic therapy].
    Beyer J; Schellong S
    Hamostaseologie; 2008 Dec; 28(5):428-37. PubMed ID: 19132172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Systemic and regional fibrinolytic treatment of peripheral arterial occlusions: proven indications?].
    Kröger K
    Hamostaseologie; 2006 Aug; 26(3):214-9. PubMed ID: 16906238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinolytic therapy.
    Klatte EC; Becker GJ; Holden RE; Yune HY
    Radiology; 1986 Jun; 159(3):619-24. PubMed ID: 3704143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Simple and effective rt-PA thrombolysis design].
    Cejna M; Salomonowitz E; Wohlschlager H; Zwrtek K; Böck R
    Rofo; 1998 Nov; 169(5):521-5. PubMed ID: 9849604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local intra-arterial fibrinolysis in acute hemispheric stroke: effect of occlusion type and fibrinolytic agent on recanalization success and neurological outcome.
    Eckert B; Kucinski T; Neumaier-Probst E; Fiehler J; Röther J; Zeumer H
    Cerebrovasc Dis; 2003; 15(4):258-63. PubMed ID: 12686789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using a peptide inhibitor of the glycoprotein IIb/IIIa platelet receptor: initial experience in patients with acute peripheral arterial occlusions.
    Yoon HC; Miller FJ
    AJR Am J Roentgenol; 2002 Mar; 178(3):617-22. PubMed ID: 11856686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of catheter-delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion: phase I results.
    Marder VJ; Comerota AJ; Shlansky-Goldberg RD; Davis JP; Deng C; Hanna K; Fineberg D
    J Thromb Haemost; 2012 Jun; 10(6):985-91. PubMed ID: 22487025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel and emerging therapies: thrombus-targeted fibrinolysis.
    Lippi G; Mattiuzzi C; Favaloro EJ
    Semin Thromb Hemost; 2013 Feb; 39(1):48-58. PubMed ID: 23034825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.